rs3781626

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002804.5(PSMC3):​c.885-615A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.65 in 151,064 control chromosomes in the GnomAD database, including 31,935 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.65 ( 31935 hom., cov: 28)

Consequence

PSMC3
NM_002804.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.17

Publications

16 publications found
Variant links:
Genes affected
PSMC3 (HGNC:9549): (proteasome 26S subunit, ATPase 3) The 26S proteasome is a multicatalytic proteinase complex with a highly ordered structure composed of 2 complexes, a 20S core and a 19S regulator. The 20S core is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. The 19S regulator is composed of a base, which contains 6 ATPase subunits and 2 non-ATPase subunits, and a lid, which contains up to 10 non-ATPase subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes one of the ATPase subunits, a member of the triple-A family of ATPases that have chaperone-like activity. This subunit may compete with PSMC2 for binding to the HIV tat protein to regulate the interaction between the viral protein and the transcription complex. A pseudogene has been identified on chromosome 9. [provided by RefSeq, Jul 2008]
PSMC3 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • neurodevelopmental disorder
    Inheritance: AD Classification: MODERATE Submitted by: G2P
  • deafness, cataract, impaired intellectual development, and polyneuropathy
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.69 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PSMC3NM_002804.5 linkc.885-615A>T intron_variant Intron 8 of 11 ENST00000298852.8 NP_002795.2 P17980A0A140VK42

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PSMC3ENST00000298852.8 linkc.885-615A>T intron_variant Intron 8 of 11 1 NM_002804.5 ENSP00000298852.3 P17980

Frequencies

GnomAD3 genomes
AF:
0.651
AC:
98228
AN:
150960
Hom.:
31930
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.618
Gnomad AMI
AF:
0.451
Gnomad AMR
AF:
0.608
Gnomad ASJ
AF:
0.696
Gnomad EAS
AF:
0.708
Gnomad SAS
AF:
0.697
Gnomad FIN
AF:
0.686
Gnomad MID
AF:
0.589
Gnomad NFE
AF:
0.668
Gnomad OTH
AF:
0.644
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.650
AC:
98261
AN:
151064
Hom.:
31935
Cov.:
28
AF XY:
0.652
AC XY:
48027
AN XY:
73716
show subpopulations
African (AFR)
AF:
0.618
AC:
25385
AN:
41082
American (AMR)
AF:
0.607
AC:
9187
AN:
15130
Ashkenazi Jewish (ASJ)
AF:
0.696
AC:
2413
AN:
3468
East Asian (EAS)
AF:
0.709
AC:
3640
AN:
5136
South Asian (SAS)
AF:
0.698
AC:
3351
AN:
4802
European-Finnish (FIN)
AF:
0.686
AC:
7044
AN:
10268
Middle Eastern (MID)
AF:
0.590
AC:
171
AN:
290
European-Non Finnish (NFE)
AF:
0.668
AC:
45322
AN:
67880
Other (OTH)
AF:
0.638
AC:
1337
AN:
2096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.514
Heterozygous variant carriers
0
1763
3526
5290
7053
8816
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
804
1608
2412
3216
4020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.533
Hom.:
1441
Bravo
AF:
0.642
Asia WGS
AF:
0.684
AC:
2374
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.59
DANN
Benign
0.56
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3781626; hg19: chr11-47442893; API